Binding molecules against BCMA and uses thereof

The present disclosure provides BCMA binding molecules that specifically bind to human BCMA, conjugates comprising the BCMA binding molecules, and pharmaceutical compositions comprising the BCMA binding molecules and the conjugates. The disclosure further provides methods of using the BCMA binding m...

Full description

Saved in:
Bibliographic Details
Main Authors Huang, Lu, Holmberg, Brian, Fleming, Tony, Hong, Connie, Blankenship, John, Lu, Haihui, Abujoub, Aida
Format Patent
LanguageEnglish
Published 08.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure provides BCMA binding molecules that specifically bind to human BCMA, conjugates comprising the BCMA binding molecules, and pharmaceutical compositions comprising the BCMA binding molecules and the conjugates. The disclosure further provides methods of using the BCMA binding molecules to treat cancers that express cell surface BCMA. The disclosure yet further provides recombinant host cells engineered to express the BCMA binding molecules and methods of producing the BCMA binding molecules by culturing the host cells under conditions in which the BCMA binding molecules are expressed.
AbstractList The present disclosure provides BCMA binding molecules that specifically bind to human BCMA, conjugates comprising the BCMA binding molecules, and pharmaceutical compositions comprising the BCMA binding molecules and the conjugates. The disclosure further provides methods of using the BCMA binding molecules to treat cancers that express cell surface BCMA. The disclosure yet further provides recombinant host cells engineered to express the BCMA binding molecules and methods of producing the BCMA binding molecules by culturing the host cells under conditions in which the BCMA binding molecules are expressed.
Author Huang, Lu
Holmberg, Brian
Blankenship, John
Fleming, Tony
Hong, Connie
Abujoub, Aida
Lu, Haihui
Author_xml – fullname: Huang, Lu
– fullname: Holmberg, Brian
– fullname: Fleming, Tony
– fullname: Hong, Connie
– fullname: Blankenship, John
– fullname: Lu, Haihui
– fullname: Abujoub, Aida
BookMark eNrjYmDJy89L5WTQd8rMS8nMS1fIzc9JTS7NSS1WSExPzMwrLlFwcvZ1VEjMS1EoLQaKlmSkFqXmp_EwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkvjQYENDE0sjEwNLJyNjYtQAANu3LCI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US11492409B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US11492409B23
IEDL.DBID EVB
IngestDate Fri Aug 23 07:04:47 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US11492409B23
Notes Application Number: US201916426914
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221108&DB=EPODOC&CC=US&NR=11492409B2
ParticipantIDs epo_espacenet_US11492409B2
PublicationCentury 2000
PublicationDate 20221108
PublicationDateYYYYMMDD 2022-11-08
PublicationDate_xml – month: 11
  year: 2022
  text: 20221108
  day: 08
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies NOVARTIS AG
RelatedCompanies_xml – name: NOVARTIS AG
Score 3.4216433
Snippet The present disclosure provides BCMA binding molecules that specifically bind to human BCMA, conjugates comprising the BCMA binding molecules, and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Binding molecules against BCMA and uses thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221108&DB=EPODOC&locale=&CC=US&NR=11492409B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKbo3nYrOCxGkb2Xa9ZI-FLFpyxC6DbfK3kbapTLBbqwd_n1PYud80beQwMkFTs75knxfAO5cDGrCNqlOzdREgNLjups6iFIyw6ZcaoxZkuAcD-x-Yj5PrWkD3rdcGKUT-qnEEdGjMvT3Su3Xq90hVqDeVpbddIFVy8do4gVajY4NCWeoFvheOBoGQ6Yx5iVjbfDiYdqPSOPe9XG73pNptNTZD199yUpZ_Q4p0RHsj9BaUR1DQxRtOGTbn9facBDXF95YrH2vPIGuv1AMFPLx_aOtKAl_Q1xfVsRn8RPhxZxsSqyVKZ1Y5qdwG4UT1tex59nPNGfJeDfI3hk0Ef6LcyAic1xjbjk5dU2p9cJphiHlIbe5LXKR0gvo_G2n81_jJbTkkilmHb2CZrXeiGsMsVV6o9bmCxBFfoY
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYrOWwTpW5luvaQPRWy7UnXthmtlb6XtUplgN2yHf9-T2Dlf9C0kcHKBk3O-JN8XgGsDgxrTFCpTJVUQoPQT2Uh1RClZT6MJ1xhTOcHZDzQvUh6n6rQBb2sujNAJ_RTiiOhRGfp7Jfbr5eYQyxFvK8tuOseqxZ0bmo5Uo-MehzNUcixzMB45I1uybTOaSMGziWk_Io0bw8Ltekvn6rw8dXqxOCtl-TukuHuwPUZrRbUPDVa0oWWvf15rw45fX3hjsfa98gC61lwwUMj794-2rCTJK-L6siKW7d-TpJiRVYm1PKVji_wQrtxBaHsy9hz_TDOOJptB9o-gifCfHQNhmW70ZqqeU0PhWi8JzTCk3OZaorGcpfQEOn_b6fzXeAktL_SH8fAheDqFXb58gmVHz6BZfazYOYbbKr0Q6_QFI1CBcw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Binding+molecules+against+BCMA+and+uses+thereof&rft.inventor=Huang%2C+Lu&rft.inventor=Holmberg%2C+Brian&rft.inventor=Fleming%2C+Tony&rft.inventor=Hong%2C+Connie&rft.inventor=Blankenship%2C+John&rft.inventor=Lu%2C+Haihui&rft.inventor=Abujoub%2C+Aida&rft.date=2022-11-08&rft.externalDBID=B2&rft.externalDocID=US11492409B2